Advertisement

Agents and Actions

, Volume 37, Issue 1–2, pp 70–79 | Cite as

A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil emigration

  • Douglas J. Ormrod
  • Thomas E. Miller
Inflammation and Immunomodulation

Abstract

An earlier study demonstrated that hyperimmunisation of dairy cows with a polyvalent bacterial vaccine stimulated the secretion of a small molecular weight anti-inflammatory moiety in the milk. This hyperimmune milk factor (HIMF) has been further investigated in the present experiments. HIMF was found to suppress the cellular phase of the response to carrageenin and also the neutrophil-dependent reverse passive Arthus reaction. These results, together with the observation that the administration of HIMF led to an increase in the number of circulating neutrophils, suggested that the agent might inhibit inflammation by interfering with the ability of neutrophils to emigrate from the vasculature.In vivo studies carried out to evaluate this possibility demonstrated that HIMF suppressed neutrophil emigration by up to 75%.In vitro experiments established that the ability of neutrophils to respond to chemotactic stimuli or adhere to endothelial cells was not affected by HIMF. It is possible, therefore, that the agent modulates inflammation by down-regulating the synthesis of inducible pro-inflammatory cytokines or adhesion molecules. Attempts are presently being made to isolate the active moiety to allow the activity of the agent at the molecular level to be studied in more detail.

Keywords

Endothelial Cell Adhesion Molecule Vitro Experiment Small Molecular Weight Active Moiety 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    R. M. Woodbury,The relationship between breast and artificial feeding and infant mortality. Am. J. Hyg.2, 668–687 (1922).Google Scholar
  2. [2]
    C. G. Grulee, H. N. Sanford and H. Schwartz,Breast and artificially fed infants. A study of the age incidence in the morbidity and mortality in twenty thousand cases. J. A. M. A.104, 1986–1988 (1935).Google Scholar
  3. [3]
    A. Lucas and T. J. Cole,Breast milk and neonatal necrotising entercolitis. Lancet336, 1519–1523 (1990).CrossRefPubMedGoogle Scholar
  4. [4]
    I. Narayanan, K. Prakash and V. V. Gujral,The value of human milk in the prevention of infection in the high-risk low-birth-weight infant. Pediatrics99, 496–498 (1986).Google Scholar
  5. [5]
    M. I. C. de Bustos, E. J. Schiffrin, K. O. de Furuya, D. V. Caccamo, M. I. L. de Paolo, D. Celener and L. Bustos-Fernandez,Prevention of carageenin-induced ulcerative colitis in the guinea pig by serum of bovine colostrum. Medicine (Buenos Aires)47, 273–277 (1987).Google Scholar
  6. [6]
    A. S. Goldman, R. M. Goldblum and L. Å. Hanson,Anti-inflammatory systems in human milk. Adv. Exp. Med. Biol.262, 69–76 (1990).PubMedGoogle Scholar
  7. [7]
    D. J. Ormrod and T. E. Miller,The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperimmunized cows. Agents and Actions32, 160–166 (1991).PubMedGoogle Scholar
  8. [8]
    L. R. Beck,Method of treating inflammation using bovine milk. United States Patent Number 4,956,349 (1990).Google Scholar
  9. [9]
    C. A. Winter, E. A. Risley and G. W. Nuss,Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med.111, 544–547 (1962).Google Scholar
  10. [10]
    D. J. Ormrod and T. E. Miller,Assessment of anti-inflammatory agents using [125I]-labelled human serum albumin to quantify footpad oedema volume in the rat. Pharmaceut. Res.8, 1270–1273 (1991).CrossRefGoogle Scholar
  11. [11]
    D. S. Fletcher, D. Osinga and R. J. Bonney,Role of polymorphonuclear leucocytes in connective tissue during the reverse passive Arthus reaction. Biochem. Pharmacol.35, 2601–2606 (1986).CrossRefPubMedGoogle Scholar
  12. [12]
    D. J. Ormrod, G. L. Harrison and T. E. Miller,Inhibition of neutrophil myeloperoxidase activity by selected tissues. J. Pharmacol. Meth.18, 137–142 (1987).CrossRefGoogle Scholar
  13. [13]
    W. Falk, R. H. Goodwin and E. J. Leonard,A 48-well micro chemotaxis assembly for rapid and accurate measurement of lecucocyte migration. J. Immunol. Meth.33, 239–247 (1980).CrossRefGoogle Scholar
  14. [14]
    B. Campbell and W. E. Petersen,Use of protective principles in milk and colostrum in prevention of disease in man and animals. Lancet75, 494–501 (1955).Google Scholar
  15. [15]
    B. Campbell and W. E. Petersen,Immune Milk—A historical survey. Dairy Science Abstracts25, 345–358 (1963).Google Scholar
  16. [16]
    B. Campbell and W. E. Petersen,Immune milk: The current picture. J. Immune Milk1, 3–28 (1964).Google Scholar
  17. [17]
    R. J. Stolle and L. R. Beck,Prevention and treatment of rheumatoid arthritis. United States Patent Number 4, 732, 757 (1988).Google Scholar
  18. [18]
    W. E. Owens and C. S. Nickerson,Evaluation of an anti-inflammatory factor derived from hyperimmunized cows. Proc. Soc. Exp. Biol. Med.190, 79–86 (1988).Google Scholar
  19. [19]
    W. E. Owens, C. S. Nickerson and P. J. Washburn,Effect of a milk-derived factor on the inflammatory response to Staphylococcus aureus intramammary infection. Vet. Immunol. Immunopathol.30, 2–3 (1992).Google Scholar
  20. [20]
    S. M. Michalek, R. L. Gregory, C. C. Harmon, J. Katz, G. J. Richardson, T. Hilton, S. J. Filler and J. R. McGhee,Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans. Infect Immun.55, 2341–2347 (1987).PubMedGoogle Scholar
  21. [21]
    S. J. Filler, R. L. Gregory, S. M. Michalek, J. Katz and J. R. McGhee,Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Arch. Oral. Biol.36, 41–47 (1991).CrossRefPubMedGoogle Scholar
  22. [22]
    C. V. Wedmore and T. J. Williams,Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature289, 646–650 (1981).CrossRefPubMedGoogle Scholar
  23. [23]
    R. J. Griffiths, S. W. Li, B. E. Wood and A. Blackham,A comparison of the anti-inflammatory activity of selected 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymozan induced inflammation in the rat knee joint and peritoneal cavity. Agents and Actions32, 312–320 (1991).PubMedGoogle Scholar
  24. [24]
    R. Vinegar and J. F. Traux,Pathways to inflammation III. Introduction to and philosophy of the symposium. Fed. Proc.46, 89–90 (1987).PubMedGoogle Scholar
  25. [25]
    T. J. Williams, P. G. Hellewell and P. J. Jose,Inflammatory mechanisms in the Arthus reaction. Agents and Actions19, 66–72 (1986).CrossRefPubMedGoogle Scholar
  26. [26]
    D. J. Ormrod, S. Cawley and T. E. Miller,Cyclosporin A modulation of acute inflammatory responses: An explanation for the effect of CsA on host defences in infection. Br. J. Exp. Path.71, 69–82 (1990).Google Scholar
  27. [27]
    B. Ryffel,Pharmacology of cyclosporin VI. Cellular activation: Regulation of intracellular events by cyclosporin. Pharmacol. Rev.41, 407–422 (1989).Google Scholar
  28. [28]
    T. E. Miller, G. Findon, S. Cawley and I. Clarke,Cellular basis of host response in pyelonephritis. II. Acute infection. Br. J. Exp. Path.67, 191–200 (1986).Google Scholar
  29. [29]
    J. Meuleman and P. Katz,The immunologic effects, kinetics and use of glucocorticosteroids. Med. Clin. North Am.69, 805–816 (1985).PubMedGoogle Scholar
  30. [30]
    A. C. Issekutz,Comparison of the effects of glucocorticoid and indomethecin treatment on the acute inflammatory reaction in rabbits. Immunopharmacology5, 183–195 (1983).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1992

Authors and Affiliations

  • Douglas J. Ormrod
    • 1
  • Thomas E. Miller
    • 1
  1. 1.Department of MedicineUniversity of AucklandAucklandNew Zealand

Personalised recommendations